Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition

被引:15
作者
Adamek, Rebecca N. [1 ]
Credille, Cy V. [1 ]
Dick, Benjamin L. [1 ]
Cohen, Seth M. [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92093 USA
来源
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2018年 / 23卷 / 07期
关键词
Fragment-based drug discovery; Hydroxypyridinethione; Inhibitor; Isostere; Metal-binding pharmacophore; Metalloenzyme; MATRIX-METALLOPROTEINASE INHIBITORS; ZINC-BINDING GROUPS; SOFT ACIDS; DISCOVERY; IDENTIFICATION; RECOGNITION; SELECTIVITY; ENVIRONMENT; PYRITHIONE; SOLUBILITY;
D O I
10.1007/s00775-018-1593-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydroxypyridinethiones (HOPTOs) are strong ligands for metal ions and potentially useful pharmacophores for inhibiting metalloenzymes relevant to human disease. However, HOPTOs have been sparingly used in drug discovery efforts due, in part, to concerns that this scaffold will act as apromiscuous, non-selective metalloenzyme inhibitor, as well as possesspoor pharmacokinetics (PK), which may undermine drug candidates containing this functional group. To advance HOPTOs as a useful pharmacophore for metalloenzyme inhibitors, a library of 22 HOPTO isostere compounds has been synthesized and investigated. This library demonstrates that it is possible to maintain the core metal-binding pharmacophore (MBP) while generating diversity in structure, electronics, and PK properties. This HOPTO library has been screened against a set of four different metalloenzymes, demonstrating that while the same metal-binding donor atoms are maintained, there is a wide range of activity between metalloenzyme targets. Overall, this work shows that HOPTO isosteres are useful MBPs and valuable scaffolds for metalloenzyme inhibitors.
引用
收藏
页码:1129 / 1138
页数:10
相关论文
共 46 条
[1]   Chelator Fragment Libraries for Targeting Metalloproteinases [J].
Agrawal, Arpita ;
Johnson, Sherida L. ;
Jacobsen, Jennifer A. ;
Miller, Melissa T. ;
Chen, Li-Hsing ;
Pellecchia, Maurizio ;
Cohen, Seth M. .
CHEMMEDCHEM, 2010, 5 (02) :195-199
[2]   Metal ions in biological catalysis: from enzyme databases to general principles [J].
Andreini, Claudia ;
Bertini, Ivano ;
Cavallaro, Gabriele ;
Holliday, Gemma L. ;
Thornton, Janet M. .
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2008, 13 (08) :1205-1218
[3]   Chemical con artists foil drug discovery [J].
Baell, Jonathan ;
Walters, Michael A. .
NATURE, 2014, 513 (7519) :481-483
[4]  
Britten CD, 2001, CLIN CANCER RES, V7, P3894
[5]   Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins [J].
Chen, Yao ;
Cohen, Seth M. .
CHEMMEDCHEM, 2015, 10 (10) :1733-1738
[6]   Computational methods for the prediction of 'drug-likeness' [J].
Clark, DE ;
Pickett, SD .
DRUG DISCOVERY TODAY, 2000, 5 (02) :49-58
[7]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[8]   Fragment-Based Identification of Influenza Endonuclease Inhibitors [J].
Credille, Cy V. ;
Chen, Yao ;
Cohen, Seth M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (13) :6444-6454
[9]   Mutational and Metal Binding Analysis of the Endonuclease Domain of the Influenza Virus Polymerase PA Subunit [J].
Crepin, Thibaut ;
Dias, Alexandre ;
Palencia, Andres ;
Swale, Christopher ;
Cusack, Stephen ;
Ruigrok, Rob W. H. .
JOURNAL OF VIROLOGY, 2010, 84 (18) :9096-9104
[10]   Design of angiotensin converting enzyme inhibitors [J].
Cushman, DW ;
Ondetti, MA .
NATURE MEDICINE, 1999, 5 (10) :1110-1112